Laxman Bahroo, DO

May 18, 2022

Robert A. Hauser, MD, MBA, and Rajesh Pahwa, MD, define the difference between ON time and OFF episodes for patients with Parkinson disease.

May 18, 2022

Rajesh Pahwa, MD, reviews the use of levodopa for the management of Parkinson disease symptoms.

April 21, 2022

Expert neurologists provide insight on unmet needs, challenges to improve access to care, and highlight clinical pearls for the management of OFF episodes in Parkinson disease.

April 21, 2022

Drs Laxman Bahroo and Sanjay Iyer comment on misconceptions and apprehensions surrounding the use of injectable therapies and the importance of patient education in this setting.

April 21, 2022

Laxman Bahroo, DO, and Sanjay Iyer, MD, discuss the efficacy and tolerability of subcutaneous and sublingual apomorphine and comment on patient selection for each formulation

April 14, 2022

Key opinion leaders in movement disorders evaluate the potential benefits and effect of an apomorphine infusion currently in development for the management of OFF episodes in Parkinson disease.

April 14, 2022

Expert neurologists review the delivery systems of various on-demand therapy formulations and comment on their advantages and disadvantages.

April 07, 2022

Laxman Bahroo, DO, and Sanjay Iyer, MD, share considerations regarding the optimization of treatment selection and the addition of on-demand therapies to manage OFF episodes in Parkinson disease.

April 07, 2022

Drs Laxman Bahroo and Sanjay Iyer assess the potential variability in levodopa absorption in the gut and its impact on OFF episodes for patients with Parkinson disease.

March 31, 2022

Expert neurologists comment on the impairment of OFF episodes on quality of life for patients and their caregivers.